Trial Profile
An Open-Label Drug-Drug Interaction Study to Assess the Effect of Rifampicin on the Pharmacokinetics of Abiraterone (JNJ-589485) Following Administration of Abiraterone Acetate (JNJ-212082) Tablets in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Rifampicin (Primary)
- Indications Prostate cancer; Tuberculosis
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 09 Aug 2012 New trial record